期刊文献+

厄多司坦原料药中有关物质的测定方法 被引量:1

HPLC determination of the related substances in erdosteine
原文传递
导出
摘要 建立厄多司坦原料药中有关物质的反相高效液相色谱测定方法。以ODS-SunFire(250 mm×4.6 mm ID,5μm)为分析柱;甲醇-乙腈-0.01 mol·L 1枸橼酸溶液(pH 2.5)(20∶4∶76)为流动相,流速为1 mL.min 1;检测波长254 nm。采用加或不加校正因子的主成分自身对照法控制原料药中有关物质。在选定的色谱条件下,厄多司坦与有关杂质分离良好。以主成分计,检测限为0.2μg.mL 1(S/N=3)。该方法能够有效地控制厄多司坦原料药中的有关物质。 An HPLC method was established for the determination of the related substance in erdosteine.Waters ODS-SunFire(250 mm 4.6 mm ID,5 μm) column was used,the mobile phase was composed of methanol-acetonitrile-0.01 mol·L?1 citric acid(20∶4∶76,the pH value was adjusted by triethylamine to 2.5).The flow rate was 1 mL·min?1.The detection wavelength was 254 nm.The related substances in the sample of erdosteine taken were calculated by self control with or without the response factor of impurity relative to that of erdosteine.Under the chromatographic condition developed,the impurities in erdosteine were isolated well.The detection limit was 0.2 μg·mL?1(Signal/Noise = 3) by principal component calculated.The method can be adopted to control the related substances in erdosteine.
机构地区 浙江大学药学院
出处 《药学学报》 CAS CSCD 北大核心 2012年第8期1039-1042,共4页 Acta Pharmaceutica Sinica
关键词 高效液相色谱法 厄多司坦 有关物质 HPLC; erdosteine; related substance
  • 相关文献

参考文献4

二级参考文献24

  • 1周向东.慢性气道炎症黏液高分泌药物治疗的现状及研究进展[J].国外医学(内科学分册),2005,32(3):115-118. 被引量:6
  • 2刘萍 边强.黏痰溶解药物--厄多司坦[J].国外医药:合成药.生化药.制剂分册,1996,17(4):239-239.
  • 3Fadillioglu E, Erdogan H, Sogut S, et al. Protective effects of erdosteine against doxorubicin-induced cardiomyopathy in rats [ J ]. J Appl Toxicol, 2003, 23( 1 ): 71 -74.
  • 4Waisman D, Brod V, Wolff R, et al. Effects of hypemxia on local and remote microcirculatory inflammatory response after splanchnic ischemia and reperfusion[J]. Am J Physiol Heart Circ Physiol, 2003, 285 ( 2 ) : H643 - H652.
  • 5Honda H M, Korge P, Weiss J N. Mitochondria and ischemia/reperfusion injury [J]. Ann NY Acad Sci, 2005, 1047:248 -258.
  • 6Cesselli D, Jakoniuk 1, Barlucchi L, et al. Oxidative stress-mediated cardiac cell death is a major determinant of ventficular dysfunction and failure in dog dilated cardiomyopathy[J]. Circ Res, 2001, 89(3) : 279 - 286.
  • 7Shiomi T, Tsutsui H, Matsusaka H, et al. Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure 'after myocardial infarction in mice[J]. Circulation, 2004, 109(4) : 544 -549.
  • 8Tunc T, Uysal B, Atabek C, et al. Erdosteine and ebselen as useful agents in intestinal ischemia/reperfusion injury[J]. J Surg Res, 2009, 155(2) : 210 -216.
  • 9Lee J Y, Kim H S, Park C S, et al. Erdosteine in renal ischemiareperfusion injury: an experimental study in pigs[J]. J Vet Med Sci, 2010, 72( 1 ) : 127 - 130.
  • 10Demiralay R, Gursan N, Ozbilim G, et al. Comparison of the effects of erdosteine and N-acetylcysteine on apoptosis regulation in endotoxin-induced acute lung injury[J]. J Appl Toxicol, 2006, 26(4) : 301 -308.

共引文献18

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部